ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this collaboration: NeoTell, an affordable, rapid, and precise device designed to measure implant stability.

ZÜRICH，2023年9月14日/PRNewswire/-今年早些时候，牙种植解决方案的先驱Neoss集团宣布与Osstell AB合作，Osstell AB是种植体稳定性测量和骨整合进展监测的全球领导者。今天，我们自豪地介绍了这项合作的第一个成果：NeoTell，一种经济实惠，快速且精确的设备，旨在测量植入物的稳定性。

NeoTell equips clinicians with the tools they need to assess implant stability swiftly and accurately, thereby improving patient outcomes and simplifying the digital workflow..

NeoTell为临床医生提供快速准确地评估种植体稳定性所需的工具，从而改善患者预后并简化数字化工作流程。。

Continue Reading

继续阅读

NeoTell will offer clinicians the means to work more efficiently and effectively

NeoTell将为临床医生提供更有效和高效的工作手段

Tweet this

推特这个

Together with Osstell, we have combined our strengths to develop a product that merges our user-friendly dental implant solutions with their extensive expertise in dental implant stability and osseointegration.

与Osstell一起，我们结合优势开发出一种产品，将我们用户友好的牙种植体解决方案与他们在牙种植体稳定性和骨整合方面的广泛专业知识相结合。

The measurement of implant stability begins with NeoTell™

植入物稳定性的测量从NeoTell开始™

'NeoTell will offer clinicians the means to work more efficiently and effectively. Our collaboration with Osstell ensures that we can provide the dental community with a comprehensive solution that enhances the predictability and success of dental implant procedures. We believe that NeoTell will become an indispensable tool for dental professionals.' – Dr.

'NeoTell将为临床医生提供更有效和高效的工作手段。我们与Osstell的合作确保我们可以为牙科界提供全面的解决方案，从而提高牙种植手术的可预测性和成功率。我们相信NeoTell将成为牙科专业人员不可或缺的工具。”博士。

Robert Gottlander, President and CEO of the Neoss Group..

Neoss集团总裁兼首席执行官Robert Gottlander。。

NeoTell empowers dental professionals with an intuitive and user-friendly device that delivers objective results without invasive procedures. With this proven technology, clinicians can make informed treatment decisions swiftly and confidently.

NeoTell为牙科专业人员提供直观，用户友好的设备，无需侵入性操作即可提供客观结果。通过这种经过验证的技术，临床医生可以迅速而自信地做出明智的治疗决策。

One of the key advantages of NeoTell is its affordability, making RFA (Resonance Frequency Analysis) technology accessible to a wide range of dental practitioners. This affordability ensures that more clinicians can leverage the benefits of RFA technology. Patients can also anticipate improved outcomes, as this technology enables more precise assessment and treatment planning, ultimately leading to greater confidence and satisfaction in their dental implant procedures.To learn more about the NeoTell, please visit https://neoss.com/neotell.About Neoss® Neoss was founded with a vision to enhance dental implant treatments for both clinicians and patients.

NeoTell的主要优势之一是其负担能力，使各种牙科医生都可以使用RFA（共振频率分析）技术。这种可负担性确保更多临床医生可以利用RFA技术的优势。患者也可以预期改善的结果，因为这项技术可以实现更精确的评估和治疗计划，最终导致他们对牙种植手术的信心和满意度更高。要了解有关NeoTell的更多信息，请访问https://neoss.com/neotell.AboutNeoss®Neoss的成立旨在为临床医生和患者提供增强牙种植体治疗的愿景。

With our extensive expertise in dental implant procedures, we are committed to develop user-friendly and cost-effective solutions that enhance the efficiency of dental professionals and improve patient outcomes. Our products and solutions are designed, researched, and developed in Gothenburg, Sweden – the birthplace of Osseointegration and the renowned pioneer, Professor Per-Ingvar Brånemark.

凭借我们在牙种植手术方面的广泛专业知识，我们致力于开发用户友好且具有成本效益的解决方案，以提高牙科专业人员的效率并改善患者的治疗效果。我们的产品和解决方案是在瑞典哥德堡设计，研究和开发的-骨整合的出生地和着名的先驱PeringvarBrånemark教授。

You can have confidence knowing that our offerings are supported by scientific research and long-term clinical results, providing you and your patients with peace of mind. To find out more visit https://neoss.comSOURCE Neoss.

您可以有信心知道我们的产品得到科学研究和长期临床结果的支持，为您和您的患者提供安心。找出更多访问https://neoss.comSOURCE新生儿。